Financial Statements · From SEC 10-K & 10-Q XBRL Filings
MRSH Revenue & Financial Statements
MRSH reported revenue of $27.0B for the fiscal year ended December 31, 2025, up 10.3% year over year, with net income of $4.2B and diluted EPS of $8.43.
- Company
- MRSH MRSH
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 19.8B | 20.7B | 22.7B | 24.5B | 27.0B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | 4.3B | 4.3B | 5.3B | 5.8B | 6.2B |
| Pretax income | 1.6B | 1.5B | 1.8B | 1.9B | 3.6B |
| Net income | 3.1B | 3.0B | 3.8B | 4.1B | 4.2B |
| Diluted EPS | 6.13 | 6.04 | 7.53 | 8.18 | 8.43 |
| EBITDA | 4.7B | 4.7B | 5.7B | 6.2B | 6.6B |
Quarterly
| USD | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.2B | 5.7B | 6.1B | 7.1B | 7.0B | 6.4B | 6.6B | 7.6B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | 1.6B | 1.1B | 1.1B | 2.0B | 1.8B | 1.2B | 1.2B | 1.8B |
| Pretax income | 1.6B | 1.0B | 1.0B | 1.8B | 1.6B | 1.0B | 1.1B | 1.6B |
| Net income | 1.1B | 747.0M | 788.0M | 1.4B | 1.2B | 747.0M | 834.0M | 1.2B |
| Diluted EPS | 2.27 | 1.51 | 1.59 | 2.79 | 2.45 | 1.51 | 1.68 | 2.36 |
| EBITDA | — | 1.2B | 1.2B | 2.1B | 1.9B | 1.3B | 1.3B | 1.8B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 34.4B | 33.5B | 48.0B | 56.5B | 58.7B |
| Current assets | 8.3B | 8.3B | 21.7B | 22.1B | 23.2B |
| Cash & equivalents | 1.8B | 1.4B | 3.4B | 2.4B | 2.7B |
| Total liabilities | — | — | — | — | — |
| Current liabilities | 6.7B | 7.2B | 19.8B | 19.5B | 21.1B |
| Long-term debt | 10.9B | 11.2B | 11.8B | 19.4B | 18.3B |
| Total debt | 10.9B | 11.5B | 11.8B | 19.4B | 18.3B |
| Stockholders’ equity | — | — | — | — | — |
| Net debt | 9.2B | 10.1B | 8.5B | 17.0B | 15.6B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 3.5B | 3.5B | 4.3B | 4.3B | 5.3B |
| Investing cash flow | (1.2B) | (850.0M) | (1.4B) | (8.8B) | (845.0M) |
| Financing cash flow | (1.3B) | (1.0B) | (1.1B) | 4.5B | (4.6B) |
| Capital expenditure | 406.0M | 470.0M | 416.0M | 316.0M | 291.0M |
| Free cash flow | 3.1B | 3.0B | 3.8B | 4.0B | 5.0B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 348.0M | 367.0M | 363.0M | 368.0M | 394.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every MRSH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.